Aligned Purpose with Our Scientific Strengths & Focus Areas

ARPA-H will have a singular purpose: to drive breakthroughs in biomedicine; to prevent, detect, and treat diseases, including cancer, Alzheimer’s, and diabetes.

President Joe Biden

…revolutionize how to prevent, treat, and even cure a range of diseases including cancer, infectious diseases, Alzheimer’s disease, and many others that together affect a significant number of Americans.

White House Office of Science and Technology Policy

Commercialization & Dynamic Talent

Massachusetts offers ARPA-H the opportunity to collaborate with and source talent from the most exciting startups in the industry, dozens of which spin out every year from world-class universities and research centers. Massachusetts’ thriving startup culture also creates a dynamic regular exchange of talent from all over the world.

In the last ten years, MA universities have spun out over 500 companies.

Drug Development Pipeline

The drug pipelines of Massachusetts headquartered biopharma companies make up 7.2 percent of the global pipeline and 15.6 percent of the U.S. pipeline. The most common therapeutic areas of the Massachusetts pipeline are oncology (34 percent), CNS (15 percent), and anti-infectives (10 percent).

Source: Evaluate, July 2022 via the MassBio 2022 Industry Snapshot